Martin Babler, President, CEO at Principia Biopharma Inc. (PRNB), sold 4,500 shares at $53.69 ($241K) on 2019-12-18, disclosed to the SEC on 2019-12-19.
Open-market sale of $241k PRNB by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.77 | 1,000 | $53K | 21.9% |
| 2 | $53.69 | 2,205 | $118K | 49.0% |
| 3 | $54.28 | 1,295 | $70K | 29.1% |
| Total | $53.66 avg | 4,500 | $241K | 100% |
| Filing → |
| PRNB | SELL | 2020-03-05 | $1.9M | — | Filing → |
| PRNB | SELL | 2019-12-19 | $2.8M | — | Filing → |
| PRNB | SELL | 2019-12-19 | $1.3M | — | Filing → |